EPCT-02. A Phase 1 Study of Mebendazole with Bevacizumab and Irinotecan in High Grade Gliomas

Authors: Julie Krystal, Derek Hanson, Danielle Donnelly, Mark Atlas

Published: 2022-06-03

DOI: 10.1093/neuonc/noac079.130

Source: Full article

---

Abstract

Abstract